-765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: A meta-analysis based on 33 case-control studies

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 277-288

  Zhu, Wei ^a   Wei, Bing Bing ^a   Shan, Xia ^a   Liu, Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; COX 2; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CARCINOMA; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG CANCER; MOUTH CANCER; PROSTATE CANCER; RISK REDUCTION; SMOKING; STOMACH CANCER; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; ENVIRONMENT; ETHNIC GROUPS; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 77949266548     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9685-1     Document Type: Article

References (60)

1. A Kirschenbaum X Liu S Yao AC Levine 2001 The role of cyclooxygenase-2 in prostate cancer Urology 58 127 131 10.1016/S0090-4295(01)01255-9 1:STN:280:DC%2BD3Mvlslehtg%3D%3D 11502467 (Pubitemid 32743428)
2. H Fujita K Koshida ET Keller Y Takahashi T Yoshimito M Namiki A Mizokami 2002 Cyclooxygenase-2 promotes prostate cancer progression Prostate 53 232 240 10.1002/pros.10152 1:CAS:528:DC%2BD38XptVGltrk%3D 12386924 (Pubitemid 35266184)
3. K Nithipatikom MA Isbell PF Lindholm A Kajdacsy-Balla S Kaul WB Campell 2002 Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion Clin Exp Metastasis 19 593 601 10.1023/A:1020915914376 1:CAS:528:DC%2BD38Xotleksbk%3D 12498388 (Pubitemid 35454569)
4. W Wang A Bergh JE Damber 2005 Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer Clin Cancer Res 11 3250 3256 10.1158/1078-0432.CCR-04-2405 1:CAS:528:DC%2BD2MXjslOqsbs%3D 15867220 (Pubitemid 40627872)
5. T Fujimura T Ohta K Oyama T Miyashita K Miwa 2006 Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience World J Gastroenterol 12 1336 1345 1:CAS:528:DC%2BD28XksVyntbw%3D 16552798
6. BP van Rees A Ristimaki 2001 Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract Scand J Gastroenterol 36 897 903 10.1080/00365520121464 11521977
7. SF Marshall L Bernstein H Anton-Culver D Deapen PL Horn-Ross H Mohrenweiser D Peel R Pinder DM Purdie P Reynolds, et al. 2005 Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status J Natl Cancer Inst 97 805 812 1:CAS:528:DC%2BD2MXkvVShtbY%3D 15928301
8. W Tan J Wu X Zhang Y Guo J Liu T Sun B Zhang D Zhao M Yang D Yu D Lin 2007 Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer Carcinogenesis 28 1197 1201 10.1093/carcin/bgl242 1:CAS:528:DC%2BD2sXnt1Cmt7s%3D 17151091 (Pubitemid 47064309)
9. LL Xing ZN Wang L Jiang Y Zhang YY Xu J Li Y Luo X Zhang 2008 Cyclooxygenase-2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index World J Gastroenterol 14 1785 1789 10.3748/wjg.14.1785 1:CAS:528:DC%2BD1cXlsVeksrY%3D 18350611
10. N Hamajima T Takezaki K Matsuo T Saito M Inoue T Hirai T Kato J Ozeki K Tajima 2001 Genotype frequencies of cyclooxygenease 2 (COX2) rare polymorphisms for Japanese with and without colorectal cancer Asian Pac J Cancer Prev 2 57 62 12718655
11. WP Koh JM Yuan D van den Berg HP Lee MC Yu 2004 Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study Br J Cancer 90 1760 1764 1:CAS:528:DC%2BD2cXkvFWlur8%3D 15150618
12. C Pereira H Sousa P Ferreira M Fragoso L Moreira-Dias C Lopes R Medeiros M Dinis-Ribeiro 2006 -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia World J Gastroenterol 12 5473 5478 1:CAS:528:DC%2BD28XhtFehtrfP 17006983
13. L Hou P Grillo ZZ Zhu J Lissowska M Yeager W Zatonski G Zhu A Baccarelli SJ Chanock JF Fraumeni Jr WH Chow 2007 COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population Anticancer Res 27 4243 4247 1:CAS:528:DC%2BD1cXhtVOmu7w%3D 18214026
14. X Zhang X Miao W Tan B Ning Z Liu Y Hong W Song Y Guo Y Shen B Qiang FF Kadlubar D Lin 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565 576 1:CAS:528:DC%2BD2MXpvVWmsbw%3D 16083713
15. R Upadhyay M Jain S Kumar UC Ghoshal B Mittal 2009 Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squamous cell carcinoma Mutat Res 663 52 59 1:CAS:528:DC%2BD1MXktlymu7k%3D 19428370
16. J Gao Q Ke HX Ma Y Wang Y Zhou ZB Hu XJ Zhai XC Wang JW Qing WS Chen GF Jin JY Liu YF Tan XR Wang HB Shen 2007 Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population J Toxicol Environ Health A 70 908 915 10.1080/15287390701289966 17479405 (Pubitemid 46699715)
17. DG Cox J Buring SE Hankinson DJ Hunter 2007 A polymorphism in the 3′ untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study Breast Cancer Res 9 R3 10.1186/bcr1635 17214885 (Pubitemid 350215158)
18. SL Chiang PH Chen CH Lee AM Ko KW Lee YC Lin PS Ho HP Tu DC Wu TY Shieh YC Ko 2008 Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2-1195G>a polymorphism reveal risk of oral cancer Cancer Res 68 8489 8498 10.1158/0008-5472.CAN-08-0823 1:CAS:528: DC%2BD1cXht1CmsbvM 18922923
19. YC Lin HI Huang LH Wang CC Tsai O Lung CY Dai ML Yu CK Ho CH Chen 2008 Polymorphisms of COX-2-765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population Oral Oncol 8 798 804 10.1016/j. oraloncology.2007.10.006
20. I Cheng X Liu SJ Plummer LM Krumroy G Casey JS Witte 2007 COX2 genetic variation, NSAIDs, and advanced prostate cancer risk Br J Cancer 97 557 561 10.1038/sj.bjc.6603874 1:CAS:528:DC%2BD2sXptVWjurk%3D 17609663 (Pubitemid 47258446)
21. RC Panguluri LO Long W Chen S Wang A Coulibaly F Ukoli A Jackson S Weinrich C Ahaghotu W Isaacs RA Kittles 2004 COX-2 gene promoter haplotypes and prostate cancer risk Carcinogenesis 6 961 966 10.1093/carcin/bgh100 (Pubitemid 38886082)
22. U Vogel J Christensen H Wallin S Friis BA Nexo A Tjonneland 2007 Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes Mutat Res 617 138 146 1:CAS:528:DC%2BD2sXjtFKgtbg%3D 17307204
23. H Yang J Gu X Lin HB Grossman Y Ye CP Dinney X Wu 2008 Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition Clin Cancer Res 14 2236 2244 10.1158/1078-0432.CCR-07-1670 1:CAS:528:DC%2BD1cXkt1arsrc%3D 18381966 (Pubitemid 351551137)
24. Peters WH, Lacko M, Te Morsche RH, Voogd AC, Oude Ophuis MB, Manni JJ (2009) COX-2 polymorphisms and the risk for head and neck cancer in white patients. Head Neck 31(7):938-943
25. C Pereira D Pinto R Catarino A Nogal D Pereira B Sousa R Medeiros 2007 COX-2 polymorphism and susceptibility to gynaecological malignancies: -765C allele confers increased risk for ovarian cancer Eur J Cancer Suppl 5 314 10.1016/S1359-6349(07)71183-7
26. D Zhao D Xu X Zhang L Wang W Tan Y Guo D Yu H Li P Zhao D Lin 2009 Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin Gastroenterology 136 1659 1668 10.1053/j.gastro.2009.01.071 1:CAS:528:DC%2BD1MXmtFWqu7s%3D 19422084
27. Z Hu X Miao H Ma X Wang W Tan Q Wei D Lin H Shen 2005 A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population Lung Cancer 48 11 17 10.1016/j.lungcan.2004.09.004 1:STN:280:DC%2BD2M7ks1GktQ%3D%3D 15777967 (Pubitemid 40380996)
28. JM Park JE Choi MH Chae WK Lee SI Cha JW Son CH Kim S Kam YM Kang TH Jung JY Park 2006 Relationship between cyclooxygenase 8473T
29. D Campa S Zienolddiny V Maggini V Skaug A Haugen F Canzian 2004 Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer Carcinogenesis 25 229 235 10.1093/carcin/bgh008 1:CAS:528:DC%2BD2cXhtVKrurY%3D 14604894 (Pubitemid 38239806)
30. D Campa RJ Hung D Mates D Zaridze N Szeszenia-Dabrowska P Rudnai J Lissowska E Fabianova V Bencko L Foretova V Janout P Boffetta P Brennan F Canzian 2005 Lack of association between polymorphisms in inflammatory genes and lung cancer risk Cancer Epidemiol Biomarkers Prev 14 538 539 10.1158/1055-9965.EPI-04-0513 1:CAS:528:DC%2BD2MXhs1Ghsb0%3D 15734985 (Pubitemid 40270124)
31. M Sorensen H Autrup A Tjonneland K Overvad O Raaschou-Nielsen 2005 A genetic polymorphism in prostaglandin synthase 2 (8473, T
32. Vogel U, Christensen J, Nexø BA, Wallin H, Friis S, Tjonneland A (2007) Peroxisome proliferator-activated receptor2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis Advance Access originally published online on September 6, 2006 Carcinogenesis 28(2):427-434 (Pubitemid 46321860)
33. J Shen MD Gammon MB Terry SL Teitelbaum AI Neugut RM Santella 2006 Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk Breast Cancer Res 8 R71 10.1186/bcr1629 17181859 (Pubitemid 350201710)
34. K Shahedi S Lindstrom SL Zheng F Wiklund J Adolfsson J Sun K Augustsson-Balter BL Chang HO Adami W Liu H Gronberg J Xu 2006 Genetic variation in the COX-2 gene and the association with prostate cancer risk Int J Cancer 119 668 672 10.1002/ijc.21864 1:CAS:528:DC%2BD28XmtlyjsLo%3D 16506214 (Pubitemid 43955722)
35. KN Danforth RB Hayes C Rodriguez K Yu LC Sakoda WY Huang BE Chen J Chen GL Andriole EE Calle EJ Jacobs LW Chu JD Figueroa M Yeager EA Platz DS Michaud SJ Chanock MJ Thun AW Hsing 2008 Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies Carcinogenesis 29 568 572 10.1093/carcin/bgm253 1:CAS:528:DC%2BD1cXjsVamsL4%3D 17999989
36. HR Ferguson CP Wild LA Anderson SJ Murphy BT Johnston LJ Murray RG Watson J McGuigan JV Reynolds LJ Hardie 2008 Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 17 727 731 10.1158/1055-9965.EPI-07-2570 1:CAS:528:DC%2BD1cXjtlKht7g%3D 18349295
37. LC Sakoda YT Gao BE Chen J Chen PS Rosenberg A Rashid J Deng MC Shen BS Wang TQ Han BH Zhang H Cohen-Webb M Yeager R Welch S Chanock JF Fraumeni Jr AW Hsing 2006 Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China Carcinogenesis 27 1251 1256 10.1093/carcin/bgi314 1:CAS:528:DC%2BD28XmsVOrsrc%3D 16361272 (Pubitemid 43985441)
38. TS Lee YT Jeon JW Kim NH Park SB Kang HP Lee YS Song 2007 Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population Ann N Y Acad Sci 1095 134 142 10.1196/annals.1397.017 1:CAS:528:DC%2BD2sXks1GktLw%3D 17404026 (Pubitemid 47092445)
39. DG Cox C Pontes E Guino M Navarro A Osorio F Canzian V Moreno 2004 Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer Br J Cancer 91 339 343 1:CAS:528:DC%2BD2cXls1ehsbg%3D 15173859
40. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
41. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 3 177 188 10.1016/0197-2456(86)90046-2 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
42. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563
43. Y Guo X Zhang W Tan X Miao T Sun D Zhao D Lin 2007 Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms Pharmacogenet Genomics 17 3 197 205 10.1097/FPC. 0b013e328010bda1 1:CAS:528:DC%2BD2sXjsVSjs74%3D 17460548 (Pubitemid 46668004)
44. JM Wang CY Ko LC Chen WL Wang WC Chang 2006 Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene Nucleic Acids Res 34 217 231 10.1093/nar/gkj422 1:CAS:528:DC%2BD28Xmsl2mtw%3D%3D 16397300 (Pubitemid 43160045)
45. A Papafili MR Hill DJ Brull RJ McAnulty RP Marshall SE Humphries GJ Laurent 2002 Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 1631 1636 10.1161/01.ATV.0000030340.80207.C5 1:CAS:528:DC%2BD38XnsVKrtr8%3D 12377741
46. LA Brosens CA Iacobuzio-Donahue JJ Keller SR Hustinx R Carvalho FH Morsink LM Hylind GJ Offerhaus FM Giardiello M Goggins 2005 Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G → C COX-2 polymorphism Clin Cancer Res 11 4090 4096 10.1158/1078-0432.CCR-04-2379 1:CAS:528:DC%2BD2MXks1Gks78%3D 15930344 (Pubitemid 40791573)
47. W Szczeklik M Sanak A Szczeklik 2004 Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma J Allergy Clin Immunol 114 248 253 10.1016/j.jaci.2004.05.030 1:CAS:528:DC%2BD2cXotVeis7s%3D 15316498 (Pubitemid 39119020)
48. SJ Cok AR Morrison 2001 The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency J Biol Chem 276 23179 23185 10.1074/jbc.M008461200 1:CAS:528:DC%2BD3MXkvValsrs%3D 11294846
49. H Sheng J Shao DA Dixon CS Williams SM Prescott RN DuBois RD Beauchamp 2000 Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA J Biol Chem 275 6628 6635 10.1074/jbc.275.9.6628 1:CAS:528:DC%2BD3cXhslWrurY%3D 10692471 (Pubitemid 30129965)
50. S Kuersten EB Goodwin 2003 The power of the 3'UTR: translational control and development Nat Rev Genet 4 626 637 10.1038/nrg1125 1:CAS:528: DC%2BD3sXlvFaqt78%3D 12897774 (Pubitemid 36917504)
51. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 1:STN:280: DyaK2M%2FhtFamsA%3D%3D 7926468
52. H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimaki 1998 Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 4997 5001 1:CAS:528:DyaK1cXnsFSmsbs%3D 9823297
53. G Chan JO Boyle EK Yang, et al. 1999 Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck Cancer Res 59 991 994 1:CAS:528:DyaK1MXhslemtLo%3D 10070952 (Pubitemid 29135955)
54. D Ratnasinghe J Tangrea MJ Roth S Dawsey N Hu M Anver QH Wang PR Taylor 1999 Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey Anticancer Res 19 171 174 1:STN:280:DyaK1M3ktlWhtA%3D%3D 10226539
55. T Hussain S Gupta H Mukhtar 2003 Cyclooxygenase-2 and prostate carcinogenesis Cancer Lett 191 125 135 10.1016/S0304-3835(02)00524-4 1:CAS:528:DC%2BD3sXhs1Klsbs%3D 12618325 (Pubitemid 36255597)
56. S Gupta M Srivastava N Ahmad DG Bostwick H Mukhtar 2000 Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma Prostate 42 73 78 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G 1:CAS:528:DC%2BD3cXisVCqtw%3D%3D 10579801 (Pubitemid 30004877)
57. JN Hirschhorn, et al. 2002 A comprehensive review of genetic association studies Genet 4 45 61 1:CAS:528:DC%2BD38XjtFSru7w%3D
58. RJ Anto A Mukhopadhyay S Shishodia CG Gairola BB Aggarwal 2002 Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB (alpha), correlation with induction of cyclooxygenase-2 Carcinogenesis 23 9 1511 1518 10.1093/carcin/23.9.1511 1:CAS:528:DC%2BD38Xms1Knt70%3D 12189195
59. T Hida K Kozaki H Ito O Miyaishi Y Tatematsu T Suzuki, et al. 2002 Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents Clin Cancer Res 8 7 2443 2447 1:CAS:528:DC%2BD38XmtVWhtL0%3D 12114451
60. JE Castelao RD Bart 3rd CA DiPerna EM Sievers RM Bremner 2003 Lung cancer and cyclooxygenase-2 Ann Thorac Surg 76 4 1327 1335 10.1016/S0003-4975(03) 00334-5 14530048 (Pubitemid 37204768)